# Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia

> **NCT02304926** · NA · COMPLETED · sponsor: **Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana** · enrollment: 42 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Ezetimibe
- **DRUG:** Simvastatin + Ezetimibe

## Key facts

- **NCT ID:** NCT02304926
- **Lead sponsor:** Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02304926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02304926, "Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02304926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*